Skip to content
Investment Visual

BMY

Bristol-Myers Squibb Company

Stock

$61.15−0.31 (−0.50%)Close Oct 2, 2026

Backtest BMY

Balance sheet

LineQ2 20262025202420232022202120202019201820172016201520142013201220112010200920082007
Cash and short-term investments$11.1B$10.7B$10.9B$12.3B$9.3B$17.0B$15.8B$15.4B$8.8B$6.8B$6.4B$4.3B$7.4B$4.5B$2.8B$8.7B$7.3B$8.5B$8.3B$1.8B
Inventory$2.7B$2.7B$2.6B$2.7B$2.3B$2.1B$2.1B$4.3B$1.2B$1.2B$1.2B$1.2B$1.6B$1.5B$1.7B$1.4B$1.2B$1.4B$1.8B—
Current assets$28.6B$29.4B$29.8B$31.8B$27.3B$33.3B$30.2B$29.4B$17.7B$14.9B$13.7B$10.4B$14.6B$18.9B$9.5B$15.3B$13.3B$14.0B$14.7B—
Goodwill$21.7B$21.8B$21.7B$21.2B$21.1B$20.5B$20.5B$22.5B$6.5B$6.9B$6.9B$6.9B$7.0B$7.1B$7.6B$5.6B$5.2B$5.2B$4.8B—
Intangible assets$17.4B$19.1B$23.3B$27.1B$35.9B$42.5B$53.2B$64.0B$1.1B$1.2B$1.4B$1.4B$1.8B$2.3B$8.8B$3.1B$3.4B$2.9B$1.2B$1.3B
Total assets$87.6B$90.0B$92.6B$95.2B$96.8B$109.3B$118.5B$129.9B$35.0B$33.6B$33.7B$31.7B$33.7B$38.6B$35.9B$33.0B$31.1B$31.0B$29.5B—
Current liabilities$18.7B$23.4B$23.8B$22.3B$21.9B$21.9B$19.1B$18.3B$10.7B$9.6B$8.8B$8.0B$8.5B$12.4B$8.3B$7.8B$6.7B$6.3B$6.7B—
Long-term debt$42.1B$42.9B$47.6B$36.7B$35.1B$39.6B$48.3B$43.4B$5.6B$7.0B$5.7B$6.6B$7.2B$8.0B$6.6B$5.4B$5.3B$6.1B$6.6B—
Total liabilities$65.3B$71.5B$76.2B$65.7B$65.7B$73.3B$80.6B$78.2B$20.9B$21.7B$17.4B$17.3B$18.8B$23.4B$22.3B$17.1B$15.4B$16.2B$17.3B—
Shareholders' equity$22.3B$18.5B$16.3B$29.4B$31.1B$35.9B$37.8B$51.6B$14.0B$11.7B$16.2B$14.3B$14.9B$15.2B$13.6B$16.0B$15.7B$14.8B$12.2B—
Shares outstanding2.04B2.04B2.03B2.02B2.10B2.18B2.24B2.26B1.63B1.63B1.67B1.67B1.66B1.65B1.64B—1.70B1.71B——
Current ratio1.531.261.251.431.251.521.581.601.661.551.551.301.731.521.151.971.972.212.19—